Search results for "Cellular Morphology"

showing 2 items of 2 documents

Hydrogel‐Based 3D Bioprinting for Bone and Cartilage Tissue Engineering

2020

As a milestone in soft and hard tissue engineering, a precise control over the micropatterns of scaffolds has lightened new opportunities for the recapitulation of native body organs through three dimentional (3D) bioprinting approaches. Well-printable bioinks are prerequisites for the bioprinting of tissues/organs where hydrogels play a critical role. Despite the outstanding developments in 3D engineered microstructures, current printer devices suffer from the risk of exposing loaded living agents to mechanical (nozzle-based) and thermal (nozzle-free) stresses. Thus, tuning the rheological, physical, and mechanical properties of hydrogels is a promising solution to address these issues. Th…

0106 biological sciences3D bioprintingMaterials scienceTissue EngineeringTissue Scaffolds010401 analytical chemistryBioprintingHydrogelsNanotechnologyGeneral MedicineHard tissue01 natural sciencesApplied Microbiology and BiotechnologyCartilage tissue engineeringBone tissue engineering0104 chemical scienceslaw.inventionCartilageBody organslaw010608 biotechnologyPrinting Three-DimensionalSelf-healing hydrogelsMolecular MedicineCellular MorphologyBiotechnology Journal
researchProduct

P11.09 Pan-RTK inhibition of sLRIG1 mediates AXL downregulation in Glioblastoma

2019

Abstract INTRODUCTION Aberrant regulation of receptor tyrosine kinase (RTK) activity is characteristic of Glioblastoma (GBM). However, RTK-based targeted therapies have been largely unsuccessful in GBM patients, partially due to the complexity and redundance of RTK signaling. LRIG1 (Leucine-rich Repeats and ImmunoGlobulindomains protein 1) is known as an endogenous inhibitor of epidermal growth factor receptor (EGFR) during health and disease, however its mechanism of action is poorly understood. We previously showed that the soluble form of LRIG1 potently inhibits of GBM growth in vivo, irrespective of EGFR expression level and status, suggesting the involvement of other RTKs. Here, we aim…

Cancer ResearchCell growthChemistrymedicine.diseasePoster PresentationsOncologyDownregulation and upregulationmedicineCancer researchNeurology (clinical)Cellular MorphologyTransluminal attenuation gradientSignal transductionGlioblastoma
researchProduct